v3.26.1
CONCENTRATION - Schedule of Operating Results (Details) - USD ($)
 3 Months Ended 6 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2025
Dec. 31, 2024
Segment Reporting [Line Items]        
Sales $ 45,100 $ 90,939 $ 232,659 $ 231,065
Cost of Goods Sold 8,564 7,842 83,444 19,177
Gross Profit 36,536 83,097 149,215 211,888
Selling Expense 31,514 8,456 52,326 23,194
Anti-Aging & Immune Support [Member]        
Segment Reporting [Line Items]        
Sales 26,805 83,348 170,754 204,396
Cost of Goods Sold 3,761 7,199 63,060 16,647
Gross Profit 23,044 76,149 107,694 187,749
Selling Expense 12,127 7,550 16,971 20,491
Targeted System Support [Member]        
Segment Reporting [Line Items]        
Sales 14,252 7,591 45,630 26,669
Cost of Goods Sold 3,308 643 14,726 2,530
Gross Profit 10,944 6,948 30,905 24,139
Selling Expense 6,237 906 12,139 $ 2,703
Herbal Insulin Support [Member]        
Segment Reporting [Line Items]        
Sales 4,043 0 16,275  
Cost of Goods Sold 1,495 0 5,658  
Gross Profit 2,548 0 10,616  
Selling Expense $ 13,150 $ 0 $ 23,216